Cityland Development (PHS:CDC) Research & Development: ₱0 Mil (TTM As of Mar. 2026)


PHS:CDC Cityland Development Corp PHS:CDC
51 GF Score
Price ₱0.57
GF Value ₱0.75
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Cityland Development Research & Development?

Cityland Development PHS:CDC -3.39% 51 Research & Development is ₱0 Mil as of Mar. 2026. GuruFocus rates PHS:CDC with a GF Score™ of 51/100 and a GF Value™ of ₱0.75 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Cityland Development's Research & Development for the three months ended in Mar. 2026 was ₱0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ₱0 Mil.

Cityland Development  (PHS:CDC) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Cityland Development Research & Development Related Terms

Cityland Development Research & Development Historical Data

* Premium members only.

The historical data trend for Cityland Development's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cityland Development Research & Development Chart

Cityland Development Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Cityland Development Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
PHS:CDC
51GF Score
Cityland Development Corp PHS:CDC
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cityland Development Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₱0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ₱0 Mil mean?
Cityland Development (PHS:CDC) has a Research & Development of ₱0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Cityland Development and its competitors.
Is Cityland Development's Research & Development too high?
Cityland Development's current Research & Development is ₱0 Mil. Overall, Cityland Development has a GF Score™ of 51/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cityland Development's Research & Development compare to CBRE and BEKE?
Cityland Development's Research & Development of ₱0 Mil can be compared against companies in the Real Estate industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Real Estate company?
A good Research & Development depends on the Real Estate industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Cityland Development and its competitors. Cityland Development's current Research & Development is ₱0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cityland Development stock overvalued right now?
Based on GuruFocus' analysis, Cityland Development (PHS:CDC) is currently considered Modestly Undervalued. The stock's GF Value™ is ₱0.75, compared to a current price of ₱0.57 — trading 24% below its estimated fair value. The current Research & Development is ₱0 Mil. Cityland Development's overall GF Score™ is 51/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Cityland Development (PHS:CDC), the current Research & Development is ₱0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cityland Development (PHS:CDC) Overvalued in 2026?

Based on GuruFocus' analysis, Cityland Development stock appears to be undervalued. The current stock price of ₱0.57 is trading 24% below its estimated GF Value™ of ₱0.75. GuruFocus considers Cityland Development to be Modestly Undervalued.

Key valuation signals for PHS:CDC:

  • Research & Development: ₱0 Mil
  • GF Value™: ₱0.75 vs. price of ₱0.57 (24% below fair value)
  • GF Score™: 51/100 with 4 warning signs

No single metric tells the full story. See the PHS:CDC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cityland Development Business Description

Address 156 H.V. Dela Costa Street, 3rd Floor, Cityland Condominium 10, Tower II, Makati, PHL, 1226
Cityland Development Corp operates as a real estate company that acquire, develop, improve, subdivide, cultivate, lease, sublease, sell, exchange, barter and/or dispose of agricultural, industrial, commercial, residential and other real properties, as well as to construct, improve, lease, sublease, sell and/or dispose of houses, buildings and other improvements thereon, and to manage and operate subdivisions and housing projects or otherwise engage in the financing and trading of real estate. Its operations are carried through the following segments: Sale of Real Estate Properties, Lease of Real Estate Properties, and Pension Plan Operations. The Company derives its revenues from the sale and lease of real estate properties and its investments in trust funds.
51GF Score

Get the complete analysis for PHS:CDC

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₱0.57
Price
₱0.75
GF Value